🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/Mpox (JYNNEOS)
← Back to VaxIQ

Mpox (JYNNEOS)

Mpox Vaccine MVA-BN (JYNNEOS)

Tier 2 · ExtendedVaccineCuration in progress

Platform: Modified vaccinia Ankara (MVA)

Vaccine that protects against mpox (monkeypox), a viral zoonotic disease related to smallpox, used in outbreak response and high-risk populations.

MVA-BNmpoxsmallpoxcross-reactiveintradermal

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Wikipedia Overview

Full article ↗
ACAM2000

ACAM2000 is a smallpox vaccine and an mpox vaccine manufactured by Emergent Biosolutions. It provides protection against smallpox for people determined to be at high risk for smallpox infection. ACAM2000 is a live replicating vaccinia virus vaccine.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.